# L&G Healthcare Technology & Innovation UCITS ETF (DOCG) **Source:** https://fundology.uk/fund/docg · ISIN IE00BK5BC677 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 01/10/2026, DOCG (L&G Healthcare Technology & Innovation UCITS ETF, ISIN IE00BK5BC677) closed at £13.93 on the London Stock Exchange. Its ongoing charge is 0.49% a year (about £49 on £10,000). Over the five years to 01/10/2026 its total return was +0.6%, or −21.3% after UK CPIH inflation. ## Summary L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD is an exchange-traded fund (ETF) from L&G, launched in 2019. It tracks the ROBO Global Healthcare Technology and Innovation Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.49% a year — about £49 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£13.93** (01/10/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | DOCG | | ISIN | IE00BK5BC677 | | Category | Technology | | Type | ETF | | Provider | L&G | | Tracks | ROBO Global Healthcare Technology and Innovation Index | | Income | Accumulating | | Ongoing charge | 0.49% a year (£49 per £10,000) | | Fund size | £202m | | Launched | 2019 | | Domicile | Ireland | ## Past returns (periods to 01/10/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +47.00% | +42.39% | income reinvested | | 3 years | +63.34% | +47.39% | income reinvested | | 5 years | +0.63% | -21.34% | income reinvested | Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published. ## Calendar-year returns Calendar-year returns of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD in pounds (price, with income reinvested in the fund): 2022 −25.9%, 2023 −6.6%, 2024 +3.5%, 2025 +17.4%; 2026 to 01/10/2026 +24.5%. Returns of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +52.4%; to 30/09/2025: +0.6%; to 30/09/2024: +7.4%; to 30/09/2023: −17.1%; to 30/09/2022: −28.1%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | -25.9% | -32.2% | Price | | 2023 | -6.6% | -10.4% | Price | | 2024 | +3.5% | -0.0% | Price | | 2025 | +17.4% | +13.4% | Price | | 2026 to 01/10/2026 | +24.5% | +21.0% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 21.22% | -14.30% | | 3 years | 19.72% | -24.69% | | 5 years | 21.49% | -46.77% | ## Largest fall Volatility of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD in pounds, annualised from weekly returns to 01/10/2026: 21.2% over 1 year, 19.7% over 3 years, 21.5% over 5 years. Largest fall in the price of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD since October 2021, in pounds: −46.8% from 05/11/2021 to 27/10/2023. The lowest 12-month return of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD in pounds (price, with income reinvested in the fund) since January 2021 was −32.3% (12 months to 17/06/2022); the highest was +50.5% (12 months to 25/09/2026). On 01/10/2026 the price of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD was 2.8% below its highest weekly close since October 2021 (05/11/2021), in pounds. ## Charges compared with similar funds Ongoing charge of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD 0.49% a year, as of 02/10/2026: 61 of the 118 other technology funds charge more, 6 the same and 51 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.49%** per year - ISA eligible: yes - SIPP eligible: yes ## Questions people ask **What is the ongoing charge of DOCG?** The ongoing charge of DOCG is 0.49% a year — about £49 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD 0.49% a year, as of 02/10/2026: 61 of the 118 other technology funds charge more, 6 the same and 51 less (share classes counted once). **What does DOCG track?** DOCG tracks the ROBO Global Healthcare Technology and Innovation Index. **Is DOCG accumulating or distributing?** DOCG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of DOCG?** The ISIN of DOCG is IE00BK5BC677. An ISIN identifies one exact share class of a fund; DOCG is its ticker on the London Stock Exchange. **What were DOCG’s returns in each of the last five years?** Calendar-year returns of DOCG in pounds (price, with income reinvested in the fund): 2022 −25.9%, 2023 −6.6%, 2024 +3.5%, 2025 +17.4%; 2026 to 01/10/2026 +24.5%. Past performance is not a guide to future returns. **How has DOCG done after inflation?** Over the five years to 01/10/2026 DOCG’s total return was +0.6%, or −21.3% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.